Air Hunger to Death:
Breathing Problems of
Hypothyroid Patients
Dr. John C. Lowe
February 25, 2005
(Updated January 30, 2006)
Send Comments & Questions to
drlowe@drlowe.com
Last week I consulted long distance with a young hypothyroid woman who had a
distressing symptom—trouble getting a deep enough breath. She told me,
"I just can’t seem to get in enough air." She said her doctor doesn’t
believe her hypothyroidism is the cause of her breathing problem.
I referred the patient to several sections of my book, The
Metabolic Treatment of Fibromyalgia.[1]
In those sections, I explain that labored breathing is a troubling symptom
for which some hypothyroid patients seek medical care.[2,
11-13, 15-24] Medical journals contain many reports of some patients
with hypothyroidism or thyroid hormone resistance having labored breathing. The
difficult breathing is called "air hunger" or "dyspnea."
Air hunger, however, isn’t the worst of the breathing troubles of some
patients with too little thyroid hormone regulation.
In The Metabolic Treatment of
Fibromyalgia,[1] I explain various
mechanisms of these patients’ air hunger, all of which result from too little
thyroid hormone regulation. One mechanism is weakness of their respiratory
muscles, including the diaphragm.[22-23]
Researchers call
this weakness of respiratory muscles "hypothyroid myopathy."
Another mechanism is impairment of the phrenic nerves that regulate contractions of the diaphragm. When
impaired, these nerves send too few signals to the diaphragm for it to contract normally.[23]
A third
mechanism is decreased "central drive of respiration."[34] This means
that the brain centers that regulate breathing are impaired by too little thyroid
hormone regulation.
Still another mechanism is abnormal heart and lung
function.[14-15,20] Some patients suffer
from air hunger only when they exert themselves; others do so even at rest.
The young hypothyroid woman I consulted with had been on T4-replacement for
three months. She had been troubled with hypothyroid symptoms, including air
hunger, for a year before her doctor diagnosed her hypothyroidism. The
T4-replacement had slightly improved her fatigue and dry skin, but not her air
hunger. Her dose of T4 was 100 mcg (0.1 mg) per day.
I was not surprised that this patient was still suffering from hypothyroid
symptoms, including air hunger. To illustrate, consider the study data reported by
a group of endocrinologists in 1997.[30]
They measured nine hypothyroid patients' TSH levels and their resting metabolic
rates, and compared them to their doses of T4. I analyzed their data from a perspective
different from theirs.
At one point in the study, six of the endocrinologists’ nine patients were
using 100 mcg (0.1 mg) of T4. For three of these patients, this dose provided
normal metabolic rates, although the rates of two of them were low normal.
These two patients’ metabolic rates were 7% and 9% below the calculated
average rate. (We consider a rate abnormally low only if it’s 10% or more
below the calculated average rate). For the other three patients on 100 mcg of T4,
the dose was woefully inadequate: One patient’s metabolic rate was 18%
below normal, another’s was 23% below, and a third patient’s was 26%
below normal.
The endocrinologists didn’t report this finding. I found it simply by
looking at their data from a different perspective. From this vantage point,
their own data show that some
hypothyroid patients are kept hypometabolic on 100 mcg of T4. We find this
regularly in our clinic when we measure the metabolic rates of patients on
T4-replacement. And 100 mcg of T4 is obviously not working for this young
woman, whose main troubling symptom is air hunger.
Doctor-Caused
Lifelong Breathing Problem.
Yesterday I consulted long distance with a woman in her seventies who has had breathing troubles
far worse than those of the young woman I
mentioned above. In the early 1970s—before the Tyranny of the TSH[32]
began—an endocrinologist treated her for hypothyroidism.
Through trial-and-error, he found that her safe and effective dose of Armour
Thyroid was 6 grains (360 mg).
She remained well on that dose until, years later, a second endocrinologist
found her TSH level suppressed. The patient had no symptoms of overstimulation.
Despite that, this endocrinologist insisted that she reduce her dose of
Amour. She complied, lowering it to 4.5 grains (270 mg).
"Soon," she told me, "I simply was not functional. I was
gasping for air and coughing so bad that I felt like I was damaging my
lungs." To breathe, she had to sit upright on a sofa without leaning
her head back to rest. This went on for eight weeks.
When her daughter, a nurse, phoned the endocrinologist, he denied that the
patient’s breathing problem was related to her lower dose of Armour. He
advised her to consult an ear, nose, and throat specialist. She saw a lung
specialist instead, and he prescribed 40 mg of cortisone and an inhaler. The
inhaler enabled her to get through her days. But even with the help of the
inhaler, she couldn’t walk up a short flight of stairs without gasping for
air. Her voice was so badly affected that she could no longer sing, which she
had always enjoyed. "I could only croak," she said.
In March of 2004, she located the original endocrinologist who
had put her on 6 grains of Armour in the early 1970s. Her put her back on that dose.
"It took me the rest of the year to get off the cortisone and get
well," she told me. "Before the second endocrinologist lowered my
Armour dose, I’d never had any asthma or other breathing problems. Now I’m
left with a lifelong breathing problem." She’s largely over the
breathing problems that began on the lower dose, but she still has to use an
inhaler one or two times each day.
I admire this woman’s strength of character in wresting control of her
health away from her doctors. Some of them have recently tried to persuade her to
lower her dose again. "They simply don’t listen when I tell them what
happened to me on the lower dose. I feel that I’m up against a wall of
idiocy," she said. "I don’t have too many years left to fool around
with their book theories, and I’m not going to let them kill me." The
tragic fact is, of course, that many doctors today would sacrifice her health
and, indeed, even her life. Like most fanatics, to these doctors any
price the patient might pay is worth achieving their obsessive goal—keeping the
patient’s TSH "in range."
Asthma.
Some inhalants patients use to relieve their asthmatic symptoms work by
stimulating beta2-adrenergic
receptors in the bronchial tubes.[28]
Stimulating the receptors dilates the tubes and constricts blood vessels
in their lining, which dries mucous secretions. These effects of the
inhalants relieve shortness of breath, coughing, and wheezing respiration.[25,p.207]
An alternative to using the inhalers is to
increase the number of beta2-adrenergic
receptors in the bronchial tubes by taking an effective daily dose of thyroid hormone.[33] T3 is especially useful for this purpose.
In 1991, Egyptian researchers treated 23 asthmatic children with T3.[29]
The children weren't hypothyroid. During the 30 days of treatment, they continued to use their usual anti-asthma drugs as
needed, but they reduced
their doses as low as they could.
The researchers wrote, "They [the children] all reported at the end of the 30 days an
obvious subjective improvement of their asthmatic conditions with a decrease in
the number of exacerbations. Seven patients stopped their usual anti-asthmatic
medicines, being maintained on T3 only and 3 have decreased the amount of
bronchodilators needed. A significant improvement of pulmonary function tests
was noted in all patients."
According to the researchers, "All patients tolerated well the T3
regimen without any adverse effect." They concluded that T3 induced
beneficial effects: T3 "proves to be a useful adjuvant to classic
anti-asthma therapy, and may reduce the amount of bronchodilators needed."
Other researchers reported that patients with asthma became hypothyroid from
using iodine-containing expectorants. After becoming hypothyroid, their
asthma worsened. The worsening of the asthma was relieved, however, when the
patients stopped using the expectorants and their thyroid function became
normal again.[27]
Another group of researchers took hypothyroid children off thyroid hormone
for a month. By the end of the month, the children's bronchial tubes became more
reactive to antigens. (Heightened reactivity of the bronchial tubes to
antigens, of course, is the basis of allergy-induced asthma.) The
children then resumed their thyroid hormone therapy. Their bronchial
tubes, however, remained more reactive to antigens for two more months. Finally,
after twenty more days, their bronchial tubes became normally reactive to antigens.[26]
Respiratory Failure
and Other Breathing Problems.
In 2004, doctors described a 36-year-old male admitted to the hospital for
progressive respiratory failure.[3] His
chest X-ray and CT scan were normal, but he had a severely slow heart rate (bradycardia)
and his cognitive function was slow. His TSH was over 150 microU/ml (in the US,
the current upper limit for a "normal" TSH is 2.5 or 3.03, depending
on which authority one consults). After the
man began thyroid hormone treatment, his respiratory function steadily
improved.
The doctors who reported this patient’s case listed five other respiratory
disorders common among hypothyroid patients: dysfunction of the diaphragm, poor
respiration from low central nervous system drive, obstruction of the airways,
pleural effusion, and sleep apnea. They advised doctors to evaluate patients
with respiratory problems for hypothyroidism.
Anesthesiologists reported the case of a
58-year old man who was severely hypothyroid. They wrote that his
hypothyroidism was the cause of "ventilatory failure." They described
his 3-to-4 breaths per minute after surgery as an "exceedingly low"
respiratory rate. The volume of air he took in each minute was low. Despite his
low oxygen intake overall, he developed "primary acute respiratory alkalosis"
(carbon dioxide loss from hyperventilation) and associated "hypocarbia"
(abnormally low carbon dioxide in arteries). The anesthesiologists cautioned
that severely hypothyroid patients are at risk for adverse events around the
time of surgery. They are more sensitive to anesthetics, have a higher
incidence of surgery-related cardiovascular disease, and have an increased risk
for ventilatory failure following surgery.[34]
Hypothyroidism doesn't have to be severe to
lead to weak breathing responses to increased carbon dioxide in the body.
Researchers published a report on ten patients with hypothyroidism less severe
than that of the patient in the above paragraph. Two of these patients had
"blunted ventilatory responses to hypercapnea." This means that high
carbon dioxide levels didn't provoke a normal increase in breathing to lower
the carbon dioxide levels. The patients' breathing responses to increased
carbon dioxide improved when they underwent thyroid hormone therapy.[35]
Continued at top of the right column . . . |
Hypothyroidism and
Obstructive Sleep Apnea. Hudgel recommended thyroid
hormone as a "ventilatory stimulant" for hypothyroid patients with
sleep-disordered breathing.[5]
He explained that in 1964, Massumi and Winnacker reported the association of
sleep-disordered breathing with hypothyroidism.[6]
Their report was about two hypothyroid patients who had obstructive sleep
apnea. In 1981, Orr reported the results of polysomnograms (recordings of
physiology during sleep) of three hypothyroid patients.[7]
The tests showed repetitive obstructive apneas during sleep. Further testing by
Rajagopal tightly linked hypothyroidism to obstructive sleep apnea.[8]
Nine of his 11 consecutive hypothyroid patients had apnea.
Not all hypothyroid patients, of course, have obstructive sleep apnea. Lin
found that among 25 hypothyroid patients, only 25% had sleep apnea.[9]
The
patients who had apnea were older and more obese than the patients without apnea.
And not all patients with obstructive sleep apnea are hypothyroid. Lin found
that only 3% of patients with apnea were hypothyroid.[9]
But for most hypothyroid patients who do
have sleep apnea, the consequences can be
troubling.[10]
For example, because they don’t sleep deeply long enough, they can
be severely fatigued throughout the day. And as the section below shows, for at
least one hypothyroid patient, apnea wasn’t just troubling; it was fatal.
First Reported Death
From Hypothyroidism and Sleep Apnea.
In 1999, doctors reported the first case of a hypothyroid
patient who suddenly died from sleep apnea.[4]
The patient was a 48-year-old man who was short and slightly overweight. He had
never been treated for his hypothyroidism.
For several years, the patient suffered from air hunger at night. In the
previous few weeks, his air hunger had worsened. In the hospital, doctors noted
that he was lucid, but his mental and physical functions were slow. They found
that he had a multinodular goiter that had moved his windpipe
(trachea) from its normal position. His tongue was enlarged, and his pharynx
(the cavity that connects the mouth and nasal passages to the esophagus) was
swollen with edema. His blood was adequately saturated with oxygen at 97%.
Doctors treated the man with T3 and hydrocortisone. They doubted that he had
sleep apnea syndrome, but they applied pulse oximetry. (Pulse oximetry is
a monitor, usually with a finger sensor, used during anesthesia and critical
care. It measures oxygen saturation of arterial blood.) The man suddenly died
seven hours later.
The oximetry record showed that over the seven-hour period, the patient had
prolonged episodes of sleep apnea. These episodes had caused deep drops in
oxygen saturation of his blood. The doctors who reported the man’s death
urged other doctors to promptly diagnose hypothyroidism that’s associated
with obstructive sleep apnea. They noted that the condition can become serious
and require intensive care with continuous nasal airway positive pressure. They
wrote that some patients may need tracheal intubation with assisted
ventilation. They cautioned, "Continuous cardiac monitoring should also be
carried out, given the risk for acute coronary complications and ventricular
arrhythmias in the early phases of substitutive therapy with thyroid
hormone."
Conclusion:
The studies I’ve cited in
this report show that too little thyroid hormone regulation can cause a variety
of breathing problems. These range from mere frustrating air hunger to death
from sleep apnea. If you have a breathing problem and your doctor can’t find
the cause, ask him or her to evaluate you for hypothyroidism or thyroid hormone
resistance. If you’re being treated for hypothyroidism with T4-replacement,
ask your doctor to consider that this thyroid hormone therapy leaves almost 50%
of patients suffering from chronic hypothyroid symptoms.[31]
Ask your doctor to also consider that you may need to switch to a more effective
therapy such as a T4/T3
combination product or T3 alone. At minimum, if your doctor isn’t aware that
too little thyroid hormone regulation can cause breathing problems, share this
special report with him or her. The doctor may use the information not only to relieve
your breathing problem, but to help other patients, too.
References

1. Lowe, J.C.:
The Metabolic Treatment of
Fibromyalgia. Boulder, McDowell Publishing Co., 2000.
2. Fujimoto, K., et al.: A case of myxedema heart
with serial endomyocardial biopsy. Kokyu to Junkan: Respir. Circul.,
40(10):1019-1023, 1992.
3. Novik, V., Perez, M.E., and Anwandter, G.: Global
respiratory failure as the presentation form of hypothyroidism. Report of
one case. Rev. Med. Chil., 132(1):81-84, 2004.
4. Pompeo A, et al.: Sudden death by sleep apnea
syndrome associated with myxedema. A case report and a review of the
literature. Minerva Endocrinol., 24(1):37-44, 1999.
5. Hudgel. D.W. and Thanakitcharu, S.: Pharmacologic
treatment of sleep-disordered breathing. Am. J. Respir. Crit. Care Med.,
158(3):691-699, 1998.
6. Massumi, R. A., and J. L. Winnacker.: Severe
depression of the respiratory center in myxedema. Am. J. Med. 36:
876-882, 1964.
7. Orr, W. C., et al.: Myxedema and obstructive
sleep apnea. Am. J. Med., 70: 1061-1066, 1981.
8. Rajagopal, K. R., et al.: Obstructive sleep apnea
in hypothyroidism. Ann. Intern. Med., 101: 491-494, 1984.
9. Lin, C., K., et al.: The relationship between
sleep apnea syndrome and hypothyroidism. Chest, 102: 1663-1667, 1992.
10. Grunstein, R. R., and C. E. Sullivan. Sleep
apnea and hypothyroidism: mechanisms and management. Am. J. Med., 85:
775-779, 1988.
11. Garcia Martinez, et al.: Heart insufficiency as
first manifestation of familial primary hypothyroidism. Rev. Esp. Cardiol.,
50(9):670-672, 1997.
12. Fiorani, S., et al.: Hypothyroidism and
megacolon. Minerva Anestesiol., 62(7-8):271-275, 1996.
13. Pincheram A., et al.: Multinodular goiter.
Epidemiology and prevention. Ann. Ital. Chir., 67(3):317-325, 1996.
14. Hellermann, J. and Kahaly, G.: Cardiopulmonary
involvement in thyroid gland diseases. Pneumologie, 50(5):375-380,
1996.
15. Ikeshita, M., et al.: A case report of
simultaneous surgery for Wolff-Parkinson-White syndrome combined with
hemolytic anemia and mitral stenosis. Jpn. Circ. J., 60(3):171-176,
1996.
16. Fujimoto, K., et al.: A case of myxedema heart
with serial endomyocardial biopsy. Kokyu To Junkan, 40(10):1019-1023,
1992.
17. Smallridge, R.C.: Metabolic and anatomic thyroid
emergencies: a review. Crit. Care Med., 20(2):276-291, 1992.
18. Nyrop, M., et al. Cardiovascular manifestations
of hypothyroidism. Ugeskr Laeger, 153(26):1849-1851, 1991.
19. Okabe, M., Kubara, K., Kawaguchi, H., et al.: A
case of myxedema with diffuse myocardial fibrosis proven by endomyocardial
biopsy. Kokyu To Junkan, 38(11):1159-1163, 1990.
20. Brussel, T., et al.: Pulmonary manifestations of
endocrine and metabolic disorders. Clin. Chest Med., 10(4):645-653,
1989.
21. Sebe, T., et al.: A case of myxedema heart
showing the improvement of impaired alpha-hANP secretion by administration
of ATP and dibutyryl cAMP. Kokyu To Junkan, 38(10):1045-1048, 1990.
22. Martinez, F.J., et al.: Hypothyroidism. A
reversible cause of diaphragmatic dysfunction. Chest,
96(5):1059-1063, 1989.
23. Laroche, C.M., et al.: Hypothyroidism presenting
with respiratory muscle weakness. Am. Rev. Respir. Dis.,
138(2):472-474, 1988.
24. Szabo, L., et al.: Thyroiditis causing upper
respiratory stenosis. Orv. Hetil. 110(24):1388-1390, 1969.
25. Harvey, R.A. and Champe, P.C.: Pharmacology.
Philadelphia, J.B. Lippincott Co., 1992.
26. Villa, M.P., et al.: Modification of nonspecific
bronchial reactivity in hypothyroid children under different regimens of
substitutive opotherapy. Pediatr. Pulmonol., 2(6):353-357, 1986.
27. Korsager, S. and Ostergaard Kristensen, H.P.:
Iodine-induced hypothyroidism and its effect on the severity of asthma.
Acta Med. Scand., 205(1-2):115-117, 1979.
28. Ursu, H.I., et al.: Graves'-Basedow's
disease--asthma association. Presentation of five cases. Rom. J.
Endocrinol., 1993;31(1-2):89-94.
29. Abdel Khalek, K., et al: Effect of
triiodothyronine on cyclic AMP and pulmonary function tests in bronchial
asthma. J. Asthma., 28(6):425-431, 1991.
30. Al-Adsani, H., et al.: Resting energy
expenditure is sensitive to small dose changes in patients on chronic
thyroid hormone replacement. Clin. Endocrin. Metab., 82(4):1118-1125,
1997.
31. Saravanan, P., et al.: Psychological well-being
in patients on ‘adequate’ doses of L-thyroxine: results of a large,
controlled community-based questionnaire study. Clin. Endocrinol. (Oxf.),
57(5):577-585, 2002.
32. Lowe, J.C.: Tyranny of the TSH. Boulder,
McDowell Publishing Co, in press.
33. Weglarz, L., et al.: Beta2-agonists: what does
their chemical structure determine? Postepy. Hig. Med. Dosw., 2004
Nov 3;58:372-80.
34. Lee, H.T. and Levine, M.: Acute respiratory
alkalosis associated with low minute ventilation in a patient with severe
hypothyroidism. Can. J. Anaesth., 46(2):185-189, 1999.
35. Ladenson, P.W., et al.: Early peripheral
responses to intravenous L-thyroxine in primary hypothyroidism. Am. J.
Med., 73(4):467-474, 1982.
|
If your doctor won't order thyroid antibody lab
tests for you, order the tests yourself. In fact, order
any
lab test you want at discounted fees through our arrangement
with Direct Labs. |
© 2011 Dr. John C.
Lowe, LLC. All rights reserved. This email newsletter may be copied and
distributed subject to three conditions: (1) All text within the full
document or any section copied must be copied without modification with
all pages included. (2) All copies must contain the following copyright
notice: "© 2011 John C. Lowe." (3) The copy of the newsletter text must
clearly show the original source of publication as "www.drlowe.com." (4)
Neither this full document nor any section of it may be published or
distributed for profit. (5) Except for personal use, the photos cannot be copied, as they are the intellectual property of individual photographers and made available
through agreement with PhotoXpress.
|